Interesting. Looks like Fairfax have publishing some pharmacy scan data again (see below). No reference to A2 sales... but some positive comments from the CEO. The rest of the article just says the Blackmores' IF has failed to penetrate the market. Surprise surprise.
http://www.smh.com.au/business/blac...ng-infant-formula-market-20160411-go3h7c.html
Baron
Interesting. Looks like Fairfax have publishing some pharmacy...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B | |||
| Open | High | Low | Value | Volume |
| $4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10795 | $4.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.83 | 5662 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |